AskMed

Liver Enzymes High? What Happens After Your Blood Test

If a blood test shows your liver enzymes high, the result is a reason to look for the cause, not a diagnosis in itself. Raised results are common: one Birmingham hospital laboratory, cited in the British Society of Gastroenterology (BSG) 2018 guideline, found at least one abnormal value in 30% of the liver test requests it received from general practices in 2016, and in a large primary care cohort fewer than 5% of people with abnormal results had a specific liver disease. What happens next depends on which enzyme is raised, by how much, and what else is going on. This guide follows the pathway set out in the American College of Gastroenterology (ACG) 2017 guideline and the BSG 2018 guideline: how to read the report, how rises are graded, whether the test is repeated, the questions about alcohol, medicines and supplements, the liver screen and ultrasound, FIB-4, referral, and when to get urgent help.

How do you read a liver enzyme report?

A liver enzyme report lists each result next to the reference range of the laboratory that ran it, and the figure that matters most is the upper limit of normal (ULN), the top of that range. Reference ranges are not universal. The ACG 2017 guideline notes that 67 reference laboratories within one US state used ALT upper limits ranging from 31 to 72 U/L, and that a normal range is usually set as the mean of a healthy population plus or minus two standard deviations, so by definition 2.5% of healthy people sit above the ULN. Because the limits differ, doctors describe a result as a multiple of the ULN: an ALT of 120 U/L on a report with a ULN of 40 is three times the ULN. A standard panel usually holds ALT, alkaline phosphatase (ALP), gamma-glutamyl transferase (GGT), bilirubin and albumin, sometimes AST, and which one is raised changes the next step as much as the size of the rise.

Doctors then look at the pattern. The ACG guideline calls it hepatocellular when ALT and AST are raised out of proportion to ALP, cholestatic when ALP leads, mixed when both are up, and isolated hyperbilirubinemia when only bilirubin is high. It also gives the R ratio, (ALT ÷ ALT ULN) ÷ (ALP ÷ ALP ULN): above 5 is hepatocellular, below 2 cholestatic and 2 to 5 mixed. A raised ALP is confirmed with a GGT first, because ALP also comes from bone; the elevated alkaline phosphatase guide covers that branch, and the elevated ALT levels guide covers the causes of a raised ALT. The ACG also points out that ALT, AST and ALP are markers of liver injury rather than liver function; albumin, bilirubin and the prothrombin time are the ones that reflect how well the liver is working.

How do doctors grade mild, moderate and severe rises?

Doctors grade a raised ALT or AST by its multiple of the upper limit of normal, and the ACG 2017 guideline uses five bands: borderline below 2 times the ULN, mild at 2 to 5 times, moderate at 5 to 15 times, severe above 15 times, and massive when ALT or AST passes 10,000 IU/L. The grade sets how fast the workup moves. Borderline and mild rises are seen in many liver and non-liver conditions and are worked up step by step. The guideline states that people with moderate, severe and massive elevations require immediate evaluation, including checks for acute viral hepatitis A to E, autoimmune hepatitis and injury from a drug or toxin. Above 15 times the ULN, or above 10,000 IU/L, it adds acetaminophen (paracetamol) toxicity and ischemic hepatopathy, also called shock liver, and it notes that rhabdomyolysis and heat stroke can raise AST to similar levels without liver disease.

ACG 2017 grades of a raised ALT or AST Example: a lab upper limit (ULN) of 40 U/L Borderline under 2× ULN (under 80) Mild 2–5× ULN (80–200) Moderate 5–15× ULN (200–600) Severe over 15× ULN (over 600) Massive over 10,000 IU/L Moderate and above: immediate evaluation
Bands from the ACG 2017 guideline. The numbers in brackets are worked out for a ULN of 40 U/L; use the ULN printed on your own report.

The grade is not the whole story. The BSG 2018 guideline warns that the extent of a liver test abnormality is not necessarily a guide to its clinical significance, and the AASLD 2023 guidance notes that aminotransferase levels are frequently normal in people with advanced liver disease from fatty liver. That is why a borderline rise still gets a proper workup, and why a normal result does not rule out scarring.

Working out the multiple and the band is simple arithmetic. Knowing which tests that band calls for is harder, because the ACG and BSG guidelines are long, organized differently and don't always agree. AskMed is a medical question app made for doctors, nurses, pharmacists, medical students and researchers. Instead of answering from memory, it searches clinical guidelines, journals and drug labels first, then writes an answer with a link after every claim. Ask it "my ALT is 130 with a lab upper limit of 40: what grade is that, and what does the ACG guideline suggest next?", and it sets out the band and the suggested workup with the guideline section one tap away, so you can read the exact wording before your appointment.

Ask AskMed what your own liver enzyme result means under the guidelines:

Will the test be repeated, and what can you do before it?

Whether a high liver enzyme result is simply repeated depends on the guideline, and the two main ones lean different ways. The ACG 2017 guideline recommends that, before an evaluation starts, the panel is repeated or a clarifying test is done, such as a GGT when ALP is raised, to confirm the result is truly abnormal. The BSG 2018 guideline advises against just repeating the same panel: in the BALLETS primary care study, 84% of abnormal tests were still abnormal one month later and 75% after two years, so a repeat on its own mostly delays the search for a cause. The BSG accepts a repeat alone only when there is a high degree of certainty that the abnormality will resolve, for example after an identified short-lived cause. The ACG algorithm runs the first liver screen and, if it is negative, considers watching with repeat tests over 3 to 6 months for a borderline rise or 3 months for a mild one.

The American Family Physician review by Oh and colleagues (2017) agrees that repeat testing is not necessary in the initial workup. Whichever approach your doctor takes, a few things before the next blood test make the result easier to interpret:

What will your doctor ask about alcohol, medicines and supplements?

After a high liver enzyme result, the history is the cheapest test and often the most useful one, and the ACG 2017 guideline tells doctors to ask about alcohol, prescribed and over-the-counter medicines, complementary and alternative medicines, and dietary or herbal supplements. For alcohol, the ACG regards women drinking more than 140 g a week and men more than 210 g a week who have an AST higher than their ALT as at risk of alcohol-related liver disease, and recommends counseling to stop. The BSG 2018 guideline uses the AUDIT questionnaire and suggests referral to alcohol services when the score is above 19. Among supplements, the ACG names chaparral, ephedra, ji bu huan, germander, green tea extract and shark cartilage as associated with liver injury, and points clinicians to LiverTox, the NIH database of drug and supplement liver injury. Doctors also ask about weight, diabetes, blood pressure, cholesterol, recent travel and any family history of liver disease.

Medicines and supplements are the part of this conversation you can prepare for, and also the hardest to check alone: a prescription label can run to dozens of pages, and supplements have no drug label at all. AskMed searches FDA and DailyMed labels alongside published studies, so you can name each product on your list and ask, for example, whether green tea extract has been linked to raised liver enzymes and how that injury was recognized. The answer points to the label section or study it comes from. Take what you find to the person who ordered the test rather than stopping a prescribed medicine on your own.

Check each medicine or supplement on your list in AskMed:

Which blood tests and scans come next?

The next tests after high liver enzymes form a liver aetiology screen, and the BSG 2018 guideline lists what it should include for adults: an abdominal ultrasound, hepatitis B surface antigen, hepatitis C antibody with a PCR test if it is positive, anti-mitochondrial, anti-smooth muscle and antinuclear antibodies, serum immunoglobulins, and ferritin with transferrin saturation. The BSG recommends considering this screen for any result outside the reference range, whatever its size or how long it has lasted. The ACG 2017 algorithm for borderline and mild rises starts with a full blood count with platelets, AST, ALT, ALP, bilirubin, albumin and the prothrombin time or INR, hepatitis B and C tests, an iron panel and an abdominal ultrasound. If the rise persists and these are negative, it adds tests for autoimmune hepatitis, ceruloplasmin for Wilson disease, especially under age 55, and the alpha-1 antitrypsin phenotype, plus tests for celiac, thyroid, muscle or tick-borne disease when the history points to them.

  1. Confirm and ask: a repeat or clarifying test (ACG), plus alcohol, medicines, supplements, weight and diabetes.
  2. First screen: blood count with platelets, bilirubin, albumin, INR, hepatitis B and C, iron studies and an abdominal ultrasound.
  3. If fatty liver is likely: a fibrosis score such as FIB-4, then elastography or an ELF blood test if it is not low.
  4. If still unexplained: autoantibodies and immunoglobulins, ceruloplasmin, alpha-1 antitrypsin, and tests chosen from the history.
  5. If no answer or a high-risk result: a liver specialist, and sometimes a liver biopsy.
The usual order for a borderline or mild rise, from the ACG 2017 algorithm and the BSG 2018 screen. Moderate and higher rises are evaluated straight away.

Ultrasound appears in both lists because it is how fatty liver is usually seen: the ACG recommends ultrasound screening for fatty liver in people with mild ALT rises and features of the metabolic syndrome, such as diabetes, overweight, high blood fats or high blood pressure. When ALP is the raised enzyme, the ACG starts with an ultrasound of the right upper abdomen to look at the bile ducts. A liver biopsy, the ACG says, may be considered when blood tests and imaging fail to give a diagnosis, to stage a condition, or when several diagnoses are possible.

What is FIB-4, and why might your doctor check it?

FIB-4 is a score that estimates the risk of advanced liver scarring, or fibrosis, from four routine values: age, AST, ALT and platelet count. Doctors use FIB-4 most when the likely cause of high liver enzymes is fatty liver disease, because the enzyme level itself says little about scarring. The AASLD 2023 guidance calls FIB-4 the most validated of the simple scores and recommends it as the first check for people with fatty liver or metabolic risk factors: below 1.3 is low risk, and at 1.3 or above a second test is used to exclude advanced fibrosis, either vibration-controlled transient elastography (FibroScan), magnetic resonance elastography or the Enhanced Liver Fibrosis (ELF) blood test. The AASLD treats 1.3 to 2.67 as intermediate and above 2.67 as high. The BSG 2018 guideline uses a low-risk line of 2.0 for people over 65, calls 1.3 to 3.25 indeterminate, and advises specialist referral above 3.25.

FIB-4 has limits. The AASLD guidance notes that it is not accurate under age 35, and that people with type 2 diabetes, pre-diabetes or two or more metabolic risk factors should have it repeated every one to two years. A low score lets most people stay with their family doctor; an intermediate one leads to the second test rather than straight to a biopsy. You can work out the score with the FIB-4 calculator and read about the condition behind most of these results in the fatty liver symptoms guide, but the number is for discussion with your doctor, who weighs it with the rest of the picture.

When will you be referred to a liver specialist?

Referral to a liver specialist, meaning a hepatologist or a gastroenterologist with an interest in liver disease, follows clear triggers in the guidelines. The BSG 2018 guideline recommends referral, or at least discussion with a specialist, for adults whose liver tests stay abnormal with a negative extended liver screen and no risk factors for fatty liver. For fatty liver, the BSG refers people with a FIB-4 above 3.25, or an indeterminate score followed by an ELF above 9.5 or a FibroScan reading above 7.8 kPa, and it sends harmful drinkers with advanced disease or a FibroScan above 16 kPa to secondary care. The ACG 2017 guideline advises referral to physicians with expertise for anyone confirmed to have chronic hepatitis B, and to a specialist for anyone with a positive hepatitis C RNA test. The AASLD 2023 guidance adds people with suspected advanced fatty liver disease or test results that disagree with each other. Referral is also the usual route to a liver biopsy.

Questions to ask your doctor

When are high liver enzymes urgent?

High liver enzymes become urgent when they come with signs that the liver is failing or the bile flow is blocked, or when the numbers are very high. The ACG 2017 guideline says that a person with acute hepatitis and a prolonged prothrombin time or encephalopathy, the confusion of liver failure, needs immediate referral to a liver specialist, and that acute liver failure requires immediate evaluation regardless of the ALT level. Moderate, severe and massive rises, above 5 times the ULN, also call for immediate evaluation. The BSG 2018 guideline says unexplained jaundice, or a suspicion of liver or bile duct cancer, should lead to immediate referral. The NHS advises asking for an urgent GP appointment or contacting NHS 111 if your skin or the whites of your eyes turn yellow, and lists itchy skin, darker urine and paler stools as other signs of jaundice. MedlinePlus warns that hepatic encephalopathy can get worse quickly and become an emergency.

Frequently asked questions

Is a high liver enzyme result serious?

Usually not on its own. In the BALLETS primary care study, fewer than 5% of people with abnormal liver tests had a specific liver disease, and in the ALFIE study only 3.9% were diagnosed with significant liver disease within 5 years. The result still needs a search for the cause.

What liver enzyme level is dangerous?

The ACG 2017 guideline calls a rise of 5 to 15 times the upper limit moderate, over 15 times severe and over 10,000 IU/L massive, and says moderate and higher rises need immediate evaluation. Any level that comes with jaundice or confusion is urgent.

Should a high liver enzyme test be repeated?

The ACG recommends repeating the panel or doing a clarifying test to confirm the result. The BSG advises against repeating it on its own, because 84% of abnormal results were still abnormal a month later, and suggests looking for the cause at the same time.

Do I need to fast before a liver blood test?

Often. MedlinePlus says you will probably be asked to fast for 10 to 12 hours. Follow the instructions you are given, and keep taking your prescribed medicines unless your doctor says otherwise.

Does a normal liver enzyme result rule out liver disease?

No. The ACG 2017 guideline states that a normal ALT may not exclude significant liver disease, and the AASLD 2023 guidance notes that aminotransferases are frequently normal in advanced fatty liver disease. That is why a fibrosis score such as FIB-4 is used when risk factors are present.

Sources

  1. Kwo PY, Cohen SM, Lim JK. ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries. Am J Gastroenterol. 2017;112(1):18-35.
  2. Newsome PN, Cramb R, Davison SM, et al. Guidelines on the management of abnormal liver blood tests. Gut. 2018;67(1):6-19.
  3. Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, et al. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology. 2023;77(5):1797-1835.
  4. Oh RC, Hustead TR, Ali SM, Pantsari MW. Mildly Elevated Liver Transaminase Levels: Causes and Evaluation. Am Fam Physician. 2017;96(11):709-715.
  5. MedlinePlus, US National Library of Medicine. Liver Function Tests. Updated December 5, 2023.
  6. MedlinePlus, US National Library of Medicine. Loss of brain function - liver disease. Reviewed July 22, 2025.
  7. NHS. Jaundice.

Cited medical answers
you can trust.

AskMed on iPhone, iPad, Android and the web.